Byun Seonjeong, Han Ji Won, Kim Tae Hui, Kim Kayoung, Kim Tae Hyun, Park Jae Young, Suh Seung Wan, Seo Ji Young, So Yoonseop, Lee Kyoung Hwan, Lee Ju Ri, Jeong Hyeon, Jeong Hyun-Ghang, Han Kyuhee, Hong Jong Woo, Kim Ki Woong
Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Department of Psychiatry, School of Medicine, Seoul National University, Seoul, Republic of Korea.
Dement Geriatr Cogn Disord. 2018;45(5-6):251-261. doi: 10.1159/000489927. Epub 2018 Jun 28.
The aim of this study was to investigate the association of gait speed and gait variability, an index of how much gait parameters, such as step time, fluctuate step-to-step, with risk of cognitive decline in cognitively normal elderly individuals. While high gait variability is emerging as an early indicator of dementing illnesses, there is little research on whether high gait variability predicts cognitive decline in cognitively normal elderly who have no evidence of cognitive impairment.
In this 4-year prospective cohort study on 91 community-dwelling cognitively normal elderly individuals without cerebral ischemic burden or Parkinsonism, we evaluated gait speed and step time variability using a tri-axial accelerometer placed on the center of body mass, and diagnosed mild cognitive impairment (MCI) according to the International Working Group on MCI. We performed Kaplan-Meier analysis with consecutive log-rank testing for MCI-free survival by cohort-specific tertiles of gait speed; hazard ratios (HR) of incident MCI were estimated using Cox proportional hazards regression analysis adjusted for age, sex, education level, Cumulative Illness Rating Scale score, GDS score, and presence of the apolipoprotein E ε4 allele.
Out of the 91 participants in the baseline assessment, 87 completed one or more 2-year follow-up assessments, and the median duration of follow-up was 47.1 months. Kaplan-Meier curves of incident MCI show evident differences in risk by gait variability group (χ2 = 9.64, p = 0.002, log-rank test). Mean MCI-free survival in the high variability group was 12% shorter than in the mid-to-low tertile group (47.4 ± 1.74 [SD] vs. 54.04 ± 0.52 months), while it was comparable between gait speed groups (51.59 ± 0.70 vs. 50.64 ± 1.77 months; χ2 = 1.16, p = 0.281). In multivariate analysis, subjects with high gait variability showed about 12-fold higher risk of MCI (HR = 11.97, 95% CI = 1.29-111.37) than those with mid-to-low variability. However, those with slow gait speed showed comparable MCI risk to those with mid-to-high speed (HR = 5.04, 95% CI = 0.53-48.18).
Gait variability may be a better predictor of cognitive decline than gait speed in cognitively normal elderly individuals without cerebral ischemic burden or Parkinsonism.
本研究旨在探讨步态速度与步态变异性(一种衡量步态参数,如步时,在步与步之间波动程度的指标)与认知功能正常的老年人认知能力下降风险之间的关联。虽然高步态变异性正逐渐成为痴呆症的早期指标,但对于没有认知障碍证据的认知功能正常的老年人,高步态变异性是否能预测认知能力下降的研究较少。
在这项针对91名居住在社区、认知功能正常、无脑缺血负担或帕金森病的老年人的4年前瞻性队列研究中,我们使用放置在身体重心处的三轴加速度计评估步态速度和步时变异性,并根据国际轻度认知障碍工作组的标准诊断轻度认知障碍(MCI)。我们通过步态速度的队列特定三分位数对无MCI生存进行连续对数秩检验的Kaplan-Meier分析;使用Cox比例风险回归分析估计发生MCI的风险比(HR),并对年龄、性别、教育水平、累积疾病评定量表评分、老年抑郁量表评分和载脂蛋白Eε4等位基因的存在进行调整。
在基线评估的91名参与者中,87人完成了一次或多次2年的随访评估,随访的中位持续时间为47.1个月。发生MCI的Kaplan-Meier曲线显示,步态变异性组之间的风险存在明显差异(χ2 = 9.64,p = 0.002,对数秩检验)。高变异性组的无MCI平均生存期比中低三分位数组短12%(47.4±1.74[标准差]对54.04±0.52个月),而步态速度组之间的生存期相当(51.59±0.70对50.64±1.77个月;χ2 = 1.16,p = 0.281)。在多变量分析中,步态变异性高的受试者发生MCI的风险比中低变异性的受试者高约12倍(HR = 11.97,95%置信区间 = 1.29 - 111.37)。然而,步态速度慢的受试者发生MCI的风险与中高速受试者相当(HR = 5.04,95%置信区间 = 0.53 - 48.18)。
对于没有脑缺血负担或帕金森病的认知功能正常的老年人,步态变异性可能比步态速度更能预测认知能力下降。